IVERIC bio, Inc.
(NASDAQ GS: ISEE)
Rigrodsky Law, P.A. is investigating IVERIC bio, Inc. (“IVERIC”) regarding possible breaches of fiduciary duties and other violations of law related to IVERIC’s agreement to be acquired by Astellas Pharma Inc. Under the terms of the agreement, IVERIC shareholders will receive $40.00 per share in cash.